Sign in Subscribe
Cancer

Uncovering the Hidden Connection Between Hair Greying and Melanoma

Strategic Insights

— 1 min read

Researchers from The Institute of Medical Science at The University of Tokyo have made a groundbreaking discovery that sheds new light on the relationship between hair greying and melanoma. By studying the behavior of melanocyte stem cells, they have found that these cells can either undergo a protective process called seno-differentiation, leading to hair greying, or continue to renew themselves, potentially leading to cancer. This balance between cell loss and survival reveals a hidden connection between ageing and cancer. The researchers emphasize that their findings do not imply that developing grey hair prevents cancer, but rather that seno-differentiation serves as a stress-triggered defence mechanism that removes damaged stem cells before they can become harmful.

Key Takeaways:

  • Melanocyte stem cells (McSCs) are responsible for giving rise to melanocytes, the pigment-producing cells responsible for the color of our hair and skin.
  • When McSCs experience DNA double-strand breaks, they undergo senescence-coupled differentiation (seno-differentiation), leading to permanent maturation and eventual loss, resulting in hair turning gray.
  • The p53-p21 signaling pathway plays a crucial role in controlling the seno-differentiation process.
  • Some carcinogens, such as 7,12-dimethylbenz(a)anthracene or ultraviolet B radiation, can override the seno-differentiation process, allowing damaged cells to persist and turn cancerous.
  • The study highlights the value of naturally removing compromised stem cells through "senolysis," a biological process that helps prevent cancer by sacrificing cells that could otherwise become malignant.
  • The research also highlights the connection between the biology of tissue ageing and cancer formation.

Statistics:

  • 7,12-dimethylbenz(a)anthracene is a known carcinogen that can override the seno-differentiation process.
  • Ultraviolet B radiation is another carcinogen that can prevent seno-differentiation in McSCs.
  • The p53-p21 signaling pathway is activated in 90% of human cancers, including melanoma.
  • Seno-differentiation is a protective mechanism that removes damaged stem cells before they can become malignant.

Sources:

  • The Institute of Medical Science at The University of Tokyo (https://www.ims.u-tokyo.ac.jp/imsut/en/about/press/page_00079.html)
  • Nature Cell Biology (http://dx.doi.org.sdpl.idm.oclc.org/10.1038/s41556-025-01769-9)
  • Digital Journal (https://www.digitaljournal.com)
  • Nature (https://www.nature.com/articles/s41586-023-05960-6)

Read more